Anti-muscarinic actions of mitoxantrone in isolated heart muscles of guinea pigs

被引:10
作者
Chugun, A
Uchide, T
Fujimori, Y
Temma, K
Hara, Y
Sasaki, T
Akera, T
机构
[1] Kitasato Univ, Sch Vet Med & Anim Sci, Dept Toxicol, Towada, Aomori 0348628, Japan
[2] Kitasato Univ, Sch Vet Med & Anim Sci, Dept Vet Pharmacol, Towada, Aomori 0348628, Japan
[3] Merck Sharp & Dohme Res Labs, Minato Ku, Tokyo 1070052, Japan
关键词
heart; mitoxantrone; anti-muscarinic action; (guinea pig);
D O I
10.1016/S0014-2999(00)00729-9
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A hypotheses that mitoxantrone is a competitive antagonist at muscarinic cholinergic receptors was examined in guinea-pig hearts. In isolated left atrial muscle preparations, electrically paced at 2 Hz, the muscarinic agonist, carbachol, caused a concentration-dependent decrease in developed tension. Mitoxantrone caused a parallel right-ward shift of the concentration-response curve for carbachol. Schild plots for the effect of mitoxantrone on the carbachol concentration-response relationship were linear with a slope of 0.88 which was not significantly different from the unity. The right-ward shift of the carbachol concentration-response relationship by mitoxantrone significantly reversed after an additional incubation with a mitoxantrone-free solution, although the reversal was incomplete after a 2-h incubation in the mitoxantrone-free solution. Mitoxantrone caused a concentration-dependent displacement of specific [H-3]quinuclidinyl benzilate binding to membrane preparations obtained from ventricular muscles of guinea-pig hearts. These results indicate that mitoxantrone acts as a competitive antagonist for the muscarinic receptors. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:183 / 189
页数:7
相关论文
共 29 条
[1]  
ALDERTON PM, 1992, CANCER RES, V52, P194
[2]  
BENJAMIN RS, 1995, SEMIN ONCOL, V22, P11
[3]   CLINICAL EVALUATION OF ADRIAMYCIN, A NEW ANTITUMOUR ANTIBIOTIC [J].
BONADONNA, G ;
MONFARDINI, S ;
DELENA, M ;
FOSSATIB.F .
BMJ-BRITISH MEDICAL JOURNAL, 1969, 3 (5669) :503-+
[4]  
BROWN J H, 1990, P150
[5]   DOXORUBICIN-INDUCED CARDIAC TOXICITY [J].
DOROSHOW, JH .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (12) :843-845
[6]   MITOXANTRONE - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC POTENTIAL IN THE CHEMOTHERAPY OF CANCER [J].
FAULDS, D ;
BALFOUR, JA ;
CHRISP, P ;
LANGTRY, HD .
DRUGS, 1991, 41 (03) :400-449
[7]  
HENDERSON BM, 1982, CANCER TREAT REP, V66, P1139
[8]   ADRIAMYCIN AND THE HEART [J].
HENDERSON, IC ;
FREI, E .
NEW ENGLAND JOURNAL OF MEDICINE, 1979, 300 (06) :310-312
[9]   RANDOMIZED CLINICAL-TRIAL COMPARING MITOXANTRONE WITH DOXORUBICIN IN PREVIOUSLY TREATED PATIENTS WITH METASTATIC BREAST-CANCER [J].
HENDERSON, IC ;
ALLEGRA, JC ;
WOODCOCK, T ;
WOLFF, S ;
BRYAN, S ;
CARTWRIGHT, K ;
DUKART, G ;
HENRY, D .
JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (05) :560-571
[10]   Comparison of the structural changes induced by doxorubicin and mitoxantrone in the heart, kidney and intestine and characterization of the Fe(III) mitoxantrone complex [J].
Herman, EH ;
Zhang, J ;
Hasinoff, BB ;
Clark, JR ;
Ferrans, VJ .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1997, 29 (09) :2415-2430